Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2010
12/23/2010WO2010115629A3 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
12/23/2010WO2010084505A3 Stable topical formulation comprising voriconazole
12/23/2010WO2010056598A3 Biodegradable alpha-2 adrenergic agonist polymeric implants
12/23/2010WO2010020798A3 Nanoparticles
12/23/2010WO2010009124A3 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
12/23/2010WO2009122252A3 Dental composition for treating peri-imlantitis
12/23/2010WO2009090558A3 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
12/23/2010US20100324529 Implant pellets and method using same
12/23/2010US20100324154 Assessing susceptibility to vascular disorders
12/23/2010US20100324126 Syn3 compositions and methods
12/23/2010US20100324120 Lipid formulation
12/23/2010US20100324031 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/23/2010US20100323981 Treatment of statin side effects
12/23/2010US20100323977 Mucoadhesive nanoparticles for cancer treatment
12/23/2010US20100323961 Surface eroding sutures
12/23/2010US20100323423 PEG-Urate Oxidase Conjugates and Use Thereof
12/23/2010US20100323422 PEG-Urate Oxidase Conjugates and Use Thereof
12/23/2010US20100323420 Regulated apoptosis
12/23/2010US20100323408 Mutant Strains of Pseudomonas Fluorescens And Variants Thereof, Methods For Their Production, And Uses Thereof In Alginate Production
12/23/2010US20100323038 Pharmaceutical Compositions
12/23/2010US20100323023 Composition for the treatment of a detached retina and method of production thereof
12/23/2010US20100322993 Injectable biocompatible composition
12/23/2010US20100322908 Compositions and methods for augmentation and regeneration of living tissue in a subject
12/23/2010US20100322902 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
12/23/2010US20100322879 Wetting and dispersing agent
12/23/2010US20100322862 Methods and compositions using peptides and proteins with c-terminal elements
12/23/2010US20100322853 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010US20100322852 Nanoparticulate compositions of angiogenesis inhibitors
12/23/2010CA2768155A1 Materials and methods relating to glycosylation
12/23/2010CA2767163A1 Dendrimer based nanodevices for therapeutic and imaging purposes
12/23/2010CA2765792A1 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
12/23/2010CA2765755A1 Anti-vegf antibodies and their uses
12/23/2010CA2765522A1 Solid pharmaceutical composition of edoxaban having improved solubility
12/23/2010CA2765188A1 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer
12/23/2010CA2765026A1 Gip receptor-active glucagon compounds
12/23/2010CA2764187A1 Stable nanoparticulate drug suspension
12/23/2010CA2763778A1 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/23/2010CA2763695A1 Drug delivery systems
12/23/2010CA2761538A1 Buccal and/or sublingual therapeutic formulation
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264065A2 Novel Insulin Derivatives
12/22/2010EP2264064A1 Modified exendins and exendin agonists
12/22/2010EP2264061A1 Compositions and methods for inhibiting viral adhesion
12/22/2010EP2264060A1 Compositions and methods for inhibiting viral adhesion
12/22/2010EP2264018A2 Thioflavin derivatives for use in the diagnosis of Alzheimer's disease
12/22/2010EP2263709A1 Medical device having hydration inhibitor
12/22/2010EP2263699A1 Solution composition for contact lenses
12/22/2010EP2263697A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
12/22/2010EP2263696A1 Method of increasing the in vivo recovery of therapeutic polypeptides
12/22/2010EP2263687A1 Immunogenic compositions containing phospholipid
12/22/2010EP2263684A1 IL-21 derivatives
12/22/2010EP2263673A1 Opioid formulations having extended controlled release
12/22/2010EP2263671A1 Amide derivative-containing pharmaceutical composition
12/22/2010EP2263662A1 Film-like composition
12/22/2010EP2263661A1 Oral preparation
12/22/2010EP2263660A2 Orally disintegrable tablets
12/22/2010EP2263656A1 Delayed release pharmaceutical formulations
12/22/2010EP2263655A1 Pharmaceutical formulation comprising atorvastatin calcium
12/22/2010EP2263654A1 Compositions and methods to improve the oral absorption of antimicrobial agents
12/22/2010EP2263653A2 Preparation of lipid based nano-particles with a dual asymetric centrifuge
12/22/2010EP2263651A2 Low viscosity liquid dosage forms
12/22/2010EP2263650A2 Nanoparticulate megestrol formulations
12/22/2010EP2263596A1 Dispensing apparatus and cartridge
12/22/2010EP2262540A2 Latency associated protein construct with aggrecanase sensitive cleavage site
12/22/2010EP2262539A1 Insulin albumin conjugates
12/22/2010EP2262538A1 Oligomer-amino acid and olgomer-atazanavir conjugates
12/22/2010EP2262537A1 Polymer paclitaxel conjugates and methods for treating cancer
12/22/2010EP2262536A2 Stabilizing lipid compositions for oral pharmaceutical agents
12/22/2010EP2262521A1 Ophthalmic compositions comprising a dipeptide
12/22/2010EP2262512A1 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries
12/22/2010EP2262506A1 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
12/22/2010EP2262493A1 Methods of treatment employing prolonged continuous infusion of belinostat
12/22/2010EP2262489A2 Hollow nanoparticles and uses thereof
12/22/2010EP2262485A1 Modified release composition comprising doxofylline
12/22/2010EP2262480A1 Immunomodulator particles and methods of treating
12/22/2010EP2262474A2 Methods and compositions for wound healing
12/22/2010EP1740166B1 Therapeutic antimicrobial compositions and methods
12/22/2010EP1626983B8 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof
12/22/2010EP1610822B1 Liquid or freeze-dried pharmaceutical formulations of fsh and/or lh together with the non-ionic surfactant poloxamer 188 and a bacteriostatic agent
12/22/2010EP1364660B1 Drug-releasing system of biodegradable polymer type
12/22/2010EP1323416B1 Process for producing medicinal solid dispersion
12/22/2010EP1214064B1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
12/22/2010CN1835722B Transdermal hormone delivery system: compositions and methods
12/22/2010CN1806823B Externally applied wind-expelling Chinese medicinal composition plaster
12/22/2010CN1547477B Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
12/22/2010CN101925612A Antibodies against cancer-associated epitope of variant nfkbib and uses thereof
12/22/2010CN101925366A Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
12/22/2010CN101925365A Nanoparticles of therapeutic agents having low water solubility
12/22/2010CN101925358A Chlorine dioxide liquid preparation composition
12/22/2010CN101925356A Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising liposome preparation
12/22/2010CN101925355A Fentanyl-containing patch for external use
12/22/2010CN101925347A Polysaccharide gel compositions and methods for sustained delivery of drugs
12/22/2010CN101923932A Multifunctional double-layer core-shell structure magnetic nano particle, preparation method and application thereof
12/22/2010CN101921739A Low-temperature xylanase XYNGR40 and gene and application thereof
12/22/2010CN101921481A Gel prepared by in situ crosslinking hyaluronic acid and polyaspartic acid and preparation method thereof
12/22/2010CN101921361A Polyacrylic resin latex for enteric medicine coating material and preparation method thereof
12/22/2010CN101921347A Hyaluronic acid derivative and drug containing the same
12/22/2010CN101921329A Alpha interferon mutant and polyethylene glycol derivative thereof
12/22/2010CN101921314A Brain-targeting neurotrophic factor fusion polypeptide for preventing and treating Alzheimer's disease
12/22/2010CN101921313A Polypeptide for curing or preventing cancer or derivative product and application thereof
1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 1712